Your browser doesn't support javascript.
loading
Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy?
Aghamiri, Shahin; Mehrjardi, Keyvan Fallah; Shabani, Sasan; Keshavarz-Fathi, Mahsa; Kargar, Saeed; Rezaei, Nima.
Afiliação
  • Aghamiri S; Student Research Committee, Department of Medical Biotechnology, School of Advanced Technology in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 19839-63113, Iran.
  • Mehrjardi KF; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, 1416753955, Iran.
  • Shabani S; Cancer Immunology Project (CIP), Universal Scientific Education & Research Network (USERN), Tehran, 1419733151, Iran.
  • Keshavarz-Fathi M; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, 1416753955, Iran.
  • Kargar S; Cancer Immunology Project (CIP), Universal Scientific Education & Research Network (USERN), Tehran, 1419733151, Iran.
  • Rezaei N; Students' Scientific Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, 1416753955, Iran.
Nanomedicine (Lond) ; 14(15): 2083-2100, 2019 08.
Article em En | MEDLINE | ID: mdl-31368405

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Portadores de Fármacos / RNA Interferente Pequeno / Nanopartículas / Terapêutica com RNAi Limite: Animals / Female / Humans Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Portadores de Fármacos / RNA Interferente Pequeno / Nanopartículas / Terapêutica com RNAi Limite: Animals / Female / Humans Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido